Media Mentions: May 2013
April 2013 May 2013 June 2013
Nanoparticles offer ‘infinite’ possibilities for cancer treatment
May 01, 2013
One of the greatest challenges associated with that disease is that it develops drug resistance to doxorubicin, said Basar Bilgicer, PhD, an assistant professor of chemical and biomolecular engineering and chemistry and biochemistry at the University of Notre Dame.
Making progress toward a treatment for dangerous allergies
May 01, 2013
"Our allergy inhibition project is innovative and significant because we brought a novel molecular design approach to selectively inhibit mast cell degranulation - the key event in triggering a food allergic response - which has the potential to improve the quality of life for affected patients," said Basar Bilgicer, assistant professor of chemical and biomolecular engineering at Notre Dame and an investigator in the University's Advanced Diagnostics & Therapeutics initiative.
New therapeutic could help prevent hypersensitive allergic reactions
May 01, 2013
It appears that partial inhibition of allergen–IgE interactions can prevent mast cell degranulation and severe allergic reaction. Basar Bilgicer, one of the study investigators, explained the importance of the work: “Our allergy inhibition project is innovative and significant because we brought a novel molecular design approach to selectively inhibit mast cell degranulation – the key event in triggering a food allergic response – which has the potential to improve the quality of life for affected patients.”